Cancer Genetics applies genomic, molecular pathology, and biomarker technologies to questions in oncology drug development and patient care. Its laboratory capabilities have included next-generation sequencing, cytogenetics, immunohistochemistry, and companion diagnostic support using tumor tissue and other clinical samples. These services help sponsors characterize disease biology, identify responsive patient populations, and incorporate biomarker strategies into preclinical and clinical programs.
Cancer Genetics, Inc.
Cancer Genetics, Inc. delivers advanced diagnostic and preclinical research services focused on precision oncology and genomic medicine. Utilizing state-of-the-art molecular pathology, next-generation sequencing, and biomarker discovery platforms, the company provides vital insights into tumor biology to guide targeted drug development and patient stratification strategy.
